BioAge Labs, Inc (BIOA)
NGS · Common · CUSIP 09077V100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BIOA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09077V100
Business: BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The Company's preclinical programs, based on novel insights from the company’s discovery platform built on human longevity data, address key pathways in metabolic aging.

Company Contact

CEO
Kristen Fortney
CFO
Dov Goldstein
Headquarters
1445A South 50th Street, , Richmond, CA 94804
Phone
510-806-1445
Investor Relations
Elena Liapounova · ir@bioagelabs.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »